346 related articles for article (PubMed ID: 31786260)
1. Current status of terpenoids as inflammasome inhibitors.
Hortelano S; González-Cofrade L; Cuadrado I; de Las Heras B
Biochem Pharmacol; 2020 Feb; 172():113739. PubMed ID: 31786260
[TBL] [Abstract][Full Text] [Related]
2. Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases.
Hua F; Shi L; Zhou P
Inflammopharmacology; 2022 Feb; 30(1):137-147. PubMed ID: 35039992
[TBL] [Abstract][Full Text] [Related]
3. The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases.
Jiang H; Gong T; Zhou R
Adv Immunol; 2020; 145():55-93. PubMed ID: 32081200
[TBL] [Abstract][Full Text] [Related]
4. The NLRP3 Inflammasome as a Pharmacological Target.
Marchetti C
J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
6. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
Zhang X; Xu A; Lv J; Zhang Q; Ran Y; Wei C; Wu J
Eur J Med Chem; 2020 Jan; 185():111822. PubMed ID: 31699536
[TBL] [Abstract][Full Text] [Related]
7. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Özenver N; Efferth T
Pharmacol Res; 2021 Aug; 170():105710. PubMed ID: 34089866
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
[TBL] [Abstract][Full Text] [Related]
9. NEK7: a potential therapy target for NLRP3-related diseases.
Liu G; Chen X; Wang Q; Yuan L
Biosci Trends; 2020 May; 14(2):74-82. PubMed ID: 32295992
[TBL] [Abstract][Full Text] [Related]
10. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.
Pellegrini C; Fornai M; Antonioli L; Blandizzi C; Calderone V
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200447
[TBL] [Abstract][Full Text] [Related]
11. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
Shim DW; Lee KH
Front Immunol; 2018; 9():1054. PubMed ID: 29868015
[TBL] [Abstract][Full Text] [Related]
12. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Arch Pharm Res; 2021 Jan; 44(1):16-35. PubMed ID: 33534121
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.
Feng X; Luo D; Wei G; Zhan F; Hua F; Xu G
Int Immunopharmacol; 2021 Nov; 100():108105. PubMed ID: 34481143
[TBL] [Abstract][Full Text] [Related]
16. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
Takahashi M
J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
Buckley LF; Libby P
J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
[TBL] [Abstract][Full Text] [Related]
18. Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes.
Gong T; Yang Y; Jin T; Jiang W; Zhou R
Trends Immunol; 2018 May; 39(5):393-406. PubMed ID: 29452983
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin alleviates NLRP3-inflammasome-mediated pyroptosis of aortic endothelial cells by inhibiting FoxO4 in arteriosclerosis.
Zhang L; Yuan M; Zhang L; Wu B; Sun X
Biochem Biophys Res Commun; 2019 Jun; 514(1):266-272. PubMed ID: 31030940
[TBL] [Abstract][Full Text] [Related]
20. Electroacupuncture attenuated cerebral ischemic injury and neuroinflammation through α7nAChR-mediated inhibition of NLRP3 inflammasome in stroke rats.
Jiang T; Wu M; Zhang Z; Yan C; Ma Z; He S; Yuan W; Pu K; Wang Q
Mol Med; 2019 May; 25(1):22. PubMed ID: 31117961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
